Search

Your search keyword '"Teh, Bin Tean"' showing total 1,390 results

Search Constraints

Start Over You searched for: Author "Teh, Bin Tean" Remove constraint Author: "Teh, Bin Tean"
1,390 results on '"Teh, Bin Tean"'

Search Results

1. Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability

4. High-throughput telomere length measurement at nucleotide resolution using the PacBio high fidelity sequencing platform

5. Lin28a maintains a subset of adult muscle stem cells in an embryonic-like state

6. Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases

8. CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma

11. Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide

13. The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women

14. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma

15. 4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancer

16. NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer

19. Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis

20. Single-cell landscape of idiopathic multicentric Castleman disease in identical twins

21. Abstract LT09: Integrative Multi-Omics Enhancer Activity Profiling Identifies Therapeutic Vulnerabilities in Cholangiocarcinoma of Different Etiologies

22. Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases

24. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing

25. Aristolochic acid‐related renal cell carcinoma exhibits a distinct tumor‐immune microenvironment favoring response to immune checkpoint blockade.

28. Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches

29. Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer

30. Facilitating a culture of responsible and effective sharing of cancer genome data

31. Establishment and characterization of a patient-derived solitary fibrous tumor/hemangiopericytoma cell line model

32. Cholangiocarcinoma

36. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma

37. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer

39. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies

40. Integrative Metabolomics, Genomics, and Transcriptomics Analysis Unravels Anti-Cancer Potential of Secondary Metabolites in Dillenia Suffruticosa

41. The prognostic value of CD39+CD8+ T cells as a potential surrogate marker of tumor-specific T cells in Asian triple-negative breast cancer

42. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma

43. Contributors

46. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

47. Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

48. Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer

49. Sex specific associations in genome wide association analysis of renal cell carcinoma

Catalog

Books, media, physical & digital resources